Dominari Holdings Inc. (DOMH)
Dominari Holdings Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as AIkido Pharma Inc. and changed its name to Dominari Holdings Inc. in December 2022. Dominari Holdings Inc. was founded in 1967 and is headquartered in New York, New York.
$13.05M
Mr. Anthony C. Hayes Esq.
4.00
New York, NY
Mar 18, 1980
-0.54
$-3.85
1.49
7.38
-231.55%
-0.52
-0.00
0.27
1.25
7.38
-44.87%
-43.75%
Similar stocks (12)
Instil Bio, Inc.
TIL
Assembly Biosciences, Inc.
ASMB
CytomX Therapeutics, Inc.
CTMX
MediciNova, Inc.
MNOV
Spero Therapeutics, Inc.
SPRO
NextCure, Inc.
NXTC
SAB Biotherapeutics, Inc.
SABS
Bolt Biotherapeutics, Inc.
BOLT
Senti Biosciences, Inc.
SNTI
Pasithea Therapeutics Corp.
KTTA
Fresh Tracks Therapeutics, Inc.
FRTX
Quoin Pharmaceuticals, Ltd.
QNRX
ETF Exposure (9)
Dimensional U.S. Targeted Value ETF
DFAT
4.5701e-4%
Dimensional U.S. Small Cap ETF
DFAS
1.0154000000000001e-4%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (12)
Instil Bio, Inc.
TIL
Assembly Biosciences, Inc.
ASMB
CytomX Therapeutics, Inc.
CTMX
MediciNova, Inc.
MNOV
Spero Therapeutics, Inc.
SPRO
NextCure, Inc.
NXTC
SAB Biotherapeutics, Inc.
SABS
Bolt Biotherapeutics, Inc.
BOLT
Senti Biosciences, Inc.
SNTI
Pasithea Therapeutics Corp.
KTTA
Fresh Tracks Therapeutics, Inc.
FRTX
Quoin Pharmaceuticals, Ltd.
QNRX
ETF Exposure (9)
Dimensional U.S. Targeted Value ETF
DFAT
4.5701e-4%
Dimensional U.S. Small Cap ETF
DFAS
1.0154000000000001e-4%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%